Expression of PD-1 and Its Ligands, PD-L1 and PD-L2, in Smokers and Never Smokers with KRAS-Mutant Lung CancerAntonio Calles, Pasi A. Jänne, Gordon J. Freeman et al.|Journal of Thoracic Oncology|2015Cited by 290
Prognostic Impact of KRAS Mutation Subtypes in 677 Patients with Metastatic Lung AdenocarcinomasHelena A. Yu, Gregory J. Riely, Camelia S. Sima et al.|Journal of Thoracic Oncology|2014Cited by 138